Clinical Trial Update: The Application of Fibrin Glue in Ocular Surface Diseases [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the use of fibrin glue for ocular surface diseases (pterygium and corneal ulcer) was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Ulcer
• Pterygium

Drugs mentioned

• Fibrin glue

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Pterygium, Corneal Ulcer | Phase 1 | Status: WITHDRAWN